Madrigal Pharmaceuticals
MDGL
#2088
Rank
โ‚น815.99 B
Marketcap
โ‚น35,127
Share price
-4.45%
Change (1 day)
-28.45%
Change (1 year)

Earnings for Madrigal Pharmaceuticals (MDGL)

Earnings in 2026 (TTM): -โ‚น11.26 Billion

According to Madrigal Pharmaceuticals 's latest financial reports the company's current earnings are โ‚น1.42 Billion. In 2025 the company made an earning of -โ‚น24.65 Billion, an increase over its 2024 earnings that were of -โ‚น41.82 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Madrigal Pharmaceuticals from 2007 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -โ‚น11.26 Billion-54.31%
2025 -โ‚น24.65 Billion-41.05%
2024 -โ‚น41.82 Billion25.02%
2023 -โ‚น33.45 Billion23.86%
2022 -โ‚น27 Billion20.24%
2021 -โ‚น22.46 Billion17.25%
2020 -โ‚น19.16 Billion117.61%
2019 -โ‚น8.81 Billion189.45%
2018 -โ‚น3.05 Billion3.85%
2017 -โ‚น2.93 Billion25.71%
2016 -โ‚น2.33 Billion-50.81%
2015 -โ‚น4.74 Billion-39.14%
2014 -โ‚น7.78 Billion-4.12%
2013 -โ‚น8.12 Billion
2011 -โ‚น4.21 Billion23.13%
2010 -โ‚น3.42 Billion-145.81%
2009 โ‚น7.46 B-185.95%
2008 -โ‚น8.69 Billion41.52%
2007 -โ‚น6.14 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
OPKO Health
OPK
-โ‚น14.75 Billion 29.01%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
-โ‚น1.69 Billion-85.28%๐Ÿ‡บ๐Ÿ‡ธ USA